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A B S T R A C T
Currently, leprosy control relies on the clinical diagnosis of leprosy and the subsequent administration of
multidrug therapy (MDT). However, many health workers are not familiar with the cardinal signs of leprosy,
particularly in low-endemic settings including Cambodia. In response, a new approach to early diagnosis was
developed in the country, namely retrospective active case ﬁnding (RACF) through small mobile teams. In the
frame of RACF, previously diagnosed leprosy patients are traced and their contacts screened through “drives”.
According to the available records, 984 of the 1,463 (67.3%) index patients diagnosed between 2001 and
2010 and registered in the national leprosy database were successfully traced in the period 2012–2015.
Migration (8.4%), death (6.7%), operational issues (1.6%) and unidentiﬁed other issues (16.0%) were the main
reasons for non-traceability. A total of 17,134 contacts of traced index patients (average: 2.2 household members
and 15.2 neighbors) and another 7,469 contacts of the untraced index patients could be screened. Among them,
264 new leprosy patients were diagnosed. In the same period, 1,097 patients were diagnosed through the routine
passive case detection system. No change was observed in the relation between the rate at which new patients
were identiﬁed and the number of years since the diagnosis of the index patient. Similar to leprosy patients
diagnosed through passive case detection, the leprosy patients detected through RACF were predominantly adult
males. However, the fraction of PB leprosy patients was higher among the patients diagnosed through RACF,
suggesting relatively earlier diagnosis.
It appears that RACF is a feasible option and eﬀective in detecting new leprosy patients among contacts of
previously registered patients. However, a well-maintained national leprosy database is essential for successful
contact tracing. Hence, passive case detection in the frame of routine leprosy surveillance is a precondition for
eﬃcient RACF as the two systems are mutually enhancing. Together, the two approaches may oﬀer an inter-
esting option for countries with low numbers of leprosy patients but evidence of ongoing transmission. The
impact on leprosy transmission could be further increased by the administration of single dose rifampicin as
post-exposure prophylaxis to eligible contacts.
1. Introduction
To date, no biomedical tests are available to easily and reliably
diagnose subclinical Mycobacterium leprae infections and leprosy dis-
ease (Roset Bahmanyar et al., 2016). Likewise, eﬃcacious vaccines
speciﬁcally targeting M. leprae remain elusive (Steinmann et al., 2017).
As a consequence, leprosy control largely depends on the recognition of
the cardinal signs of leprosy disease by a health worker, followed by
administration of multidrug therapy (MDT) (Smith et al., 2017). Early
diagnosis is important for two main reasons: to reduce the risk that the
patient develops irreversible disability, and to shorten the time the
patient can contribute to the transmission of the infection (Smith et al.,
2014; Smith and Aerts, 2014, 2015). As a relatively rare disease with
initially inconspicuous and painless symptoms that can easily be mis-
taken for other dermatological conditions, health workers often lack
experience to recognize the cardinal signs of leprosy. Further, patients
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tend to overlook symptoms and do not seek medical attention at an
early stage. Consequently, leprosy is often ignored or diagnosed late,
and a considerable proportion of newly detected leprosy patients suﬀer
from severe morbidity (Anonymous, 2015).
To shorten the delay between the onset of leprosy disease and di-
agnosis, contribute to the training of the health workforce, and raise
awareness among the public; mass campaigns and targeted group
screenings are conducted in many leprosy-endemic countries
(Schreuder et al., 2002). Typically, such activities focus on high-in-
cidence communities, but they can also have more general reach.
Further, they usually focus on the contacts of newly diagnosed leprosy
patients since prolonged contact with an untreated leprosy patient is
one of the key risk factors for developing leprosy disease (Moet et al.,
2004; Moet et al., 2006). Contacts are usually categorized as household
members, neighbors and social contacts such as class mates and co-
workers. Close contact for more than 20 h per week and over several
weeks has been recognized as the main threshold for increased risk of
leprosy disease among contacts (Smith and Aerts, 2014). The contact
deﬁnition applied in a speciﬁc programme depends on the local level of
stigma, resources and operational feasibility.
In 1998, Cambodia reached the WHO-deﬁned threshold of leprosy
elimination, namely<1 case per 10,000 population (CENAT – National
Center for Tuberculosis and Leprosy, 2005). Unfortunately, this
achievement has resulted in a diversion of attention to other public
health issues. Human and material resources dedicated to leprosy
control have consequently diminished, along with public interest in the
disease and internal and external ﬁnancial support to leprosy control.
However, over one hundred new leprosy patients continue to be diag-
nosed in the country every year through passive case detection (2016:
n=154 (Anonymous, 2017)), and there is evidence for both, ongoing
transmission (i.e. pediatric patients) and considerable delay until di-
agnosis (i.e. grade II disability) (Anonymous, 2015). Contrary to other
countries, in Cambodia the contacts of newly diagnosed leprosy pa-
tients are not routinely traced and screened for signs of leprosy. In re-
sponse, a unique approach to leprosy control has been developed in
Cambodia, building on the concept of retrospective active case ﬁnding
(RACF) that had been developed in the frame of tuberculosis control
(Morishita et al., 2016).
In this article, we summarize the Cambodian experience with RACF
to amplify the eﬀorts for leprosy control in the country. We report on
the feasibility and eﬀectiveness of RACF as compared to the routine
activities and summarize ﬁrst ﬁndings. Last, we discuss future per-
spectives and integration with other innovative approaches for leprosy
control. A special focus is on the coverage achieved with this approach,
the optimal time span from diagnosis of the index patient until contact
tracing and screening, and on the characteristics of the leprosy patients
diagnosed through RACF as compared to those diagnosed through
routine program activities.
2. Materials and methods
2.1. RACF and its implementation in Cambodia
The RACF project was jointly developed by the Cambodian National
Leprosy Elimination Programme (NLEP), the Campagne Internationale
de L’Ordre de Malte contre la Lèpre (CIOMAL) and Novartis
Foundation. An inclusive contact deﬁnition was used that covered all
household members and neighbors living within a radius of about
200m around an index patient diagnosed in the country between 2001
and the onset of the program in 2011. The national database of leprosy
patients in the country provided the starting point to trace index pa-
tients. The list was completed based on local records since the national
list apparently was incomplete and address details for the index patients
were sometimes missing. The tracing of the index patient and the
screening of their contacts for signs of leprosy disease was then im-
plemented by a mobile team in the frame of “drives” that systematically
covered all 78 operational districts (OD) of the country until all ODs
had been visited at least once; a goal achieved in 2015. The scheduling
of the drives took the rainy season (ca. July-October) into account as
periodic ﬂooding compromises access to some areas. The mobile team
included experienced leprologists from NLEP and CIOMAL, province-
and district-level leprosy control staﬀ, and local health care personnel.
In parallel, routine leprosy control activities, namely passive case de-
tection, continued throughout the country.
The ﬁnal drive protocol was developed based on the experience
gained through three initial drives during which the contacts of 1,818
index patients in 25 ODs had been screened and 277 new leprosy pa-
tients had been diagnosed. Similarly, the documentation of the drive
activities evolved over time. Standardized documentation is available
from drive 4 onwards.
In brief, ﬁeld activities included a theatre play to raise awareness for
leprosy in general and for the RACF mission in particular. The following
day, index patients were visited and re-examined to conﬁrm their le-
prosy status. Then, the household members of the index patient were
screened for signs of leprosy disease, followed by the neighbors.
Possible new leprosy patients identiﬁed through the screening process
were examined by an experienced leprologist and diagnosis conﬁrmed
on the day of the drive. For newly detected patients, MDT was initiated
immediately. Drive documentation focused on the newly diagnosed
leprosy patients and on the household contacts for which individual
demographic data were collected. From neighbor contacts without any
signs of leprosy disease, only summary data were obtained (e.g. number
of contacts screened).
2.2. Data analysis
Following the completion of the ﬁrst phase of the RACF project,
namely once all ODs had been visited at least once, all drive data were
entered into a single database. Available data from the RACF drives
included the general reports from the project build-up phase (drives
1–3) and detailed data from the fully operational phase (drives 4–11).
However, as the procedures and reporting were designed, tested and
continuously revised during the build-up phase of the RACF project,
and no individual data were collected during the build-up phase, only
data from drives 4–11 were considered in the current analysis. Also
excluded from the more detailed analysis was both data on patients not
initially included in the national leprosy database and data on their
respective contacts. To compare the performance of RACF with routine
activities, annual data from the national leprosy control programme
were obtained from NLEP for the years 2001–2015. All data were stored
in Microsoft Excel 2010 (Microsoft Corporation, Redmond, Washington,
United States of America); data management and analysis was done in
Stata version 14 (Stata Corporation, College Station, Texas, United
States of America).
Descriptive statistics was used to summarize key RACF and NLEP
data with the aim to investigate the feasibility of RACF, describe the
main characteristics of the index patients and newly detected leprosy
patients among their contacts, and evaluate the eﬀectiveness of RACF as
compared to the routine activities in Cambodia. The feasibility of RACF
was assessed through (i) the percentage of index patients that had been
traced successfully; (ii) the number of household members and neigh-
bors that were successfully screened, stratiﬁed by the presence or ab-
sence of the index patient on the screening day; (iii) the number of new
leprosy patients detected among the contacts, stratiﬁed by household
and neighbor contacts; and (iv) the fraction of new leprosy patients
among contacts in relation to the number of years since the diagnosis of
the index patient.
Standard demographic and leprosy-speciﬁc variables were used to
characterize the index patients and newly detected leprosy patients
among their contacts: sex (male/female), age group (≤15 years
and> 15 years of age), disability grade (DG) 0, I or II, and leprosy type
(paucibacillary (PB)/multibacillary (MB)).
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The eﬀectiveness of RACF in Cambodia was described in terms of
the total number of newly detected leprosy patients detected through
passive case detection and RACF respectively. Particular attention is on
shifts in the proportion of patients with MB or PB in the districts over
the years and depending on the detection method.
3. Results
3.1. Feasibility of RACF—tracing of index patients and their contacts
Overall, 1,463 leprosy patients in 54 ODs who had been diagnosed
between 2001 and 2010 and registered in the NLEP national leprosy
database were identiﬁed as index patients for the RACF drives 4–11
(Fig. 1). These index patients belonged to 1,287 diﬀerent households.
Of the 1,463 index patients, 67.3% were successfully traced during the
RACF drives 4–11 in the years 2012–2015. Reasons for non-retrieval of
index patients were death (6.7%), migration (8.4%), operational issues
(e.g. inaccessibility of an area; 1.6%), and unidentiﬁed other issues
(16.0%). No clear trend in tracing rates over time could be observed. A
total of 24,603 contacts of these index patients were screened: on
average, 2.2 household members and 15.2 neighbors per traced index
patient and 1.7 household members and 13.9 neighbors per missed
index patient.
In 12 out of the 54 ODs (22.2%) covered by the drives 4–11 the
index patient tracing rate was lower than 50%. In the three ODs (5.6%)
where no index patients could be traced, a maximum of three index
patients had been listed in the NLEP national leprosy database and
identiﬁed for follow-up. In 29 ODs (53.7%), at least 70% of the index
patients could be traced, including 15 ODs (27.8%) where at least 80%
of the index patients were traced. Overall, no clear relationship became
apparent between the number of index patients and the tracing rate.
Similarly, no relationship between diﬀerent reasons for reported non-
traceability of index patients could be identiﬁed.
3.2. Feasibility of RACF—diagnosis of leprosy patients
A total of 1,097 leprosy patients have been newly listed in the NLEP
national leprosy database from 2012–2015. Over the same period,
RACF identiﬁed 264 new leprosy patients. Speciﬁcally, through RACF a
total of 201 new patients were diagnosed among the 17,134 household
members and neighbors of the successfully traced index patients, which
translates into a new case detection rate (NCDR) of 11.7 per 1,000
contacts screened (Table 1). Likewise, RACF identiﬁed 63 new leprosy
patients among the 7,469 screened household members and neighbors
of the index patients that could not be traced, a NCDR of 8.4 per 1,000
contacts screened. Overall, 75 new leprosy patients were identiﬁed
among the 2,987 screened household members (NCDR household
member screening=25.1) and 189 were diagnosed among the 21,616
screened neighbors (NCDR neighbors screening= 8.7).
Index patients traced in the frame of the RACF project were diag-
nosed between 2001–2010, and new leprosy patients among their
contacts were diagnosed between 2012–2015. Hence, there is a
minimum of two years and a maximum of 14 years between the diag-
nosis of an index patient and the tracing and screening of contacts. A
Fig. 1. Tracing of index patients and
screening of their contacts, stratiﬁed by
tracing status. Index patients were diag-
nosed in the years 2001–2010 and traced in
the years 2012–2015 in the frame of drives
4–11 of the retrospective active case ﬁnding
(RACF) project in Cambodia.
Table 1
Outcome of contact screening for signs of leprosy disease in the frame of drives 4–11 of the retrospective active case ﬁnding (RACF) project in Cambodia 2012–2015, stratiﬁed by contact
type and tracing status of the index patient.
Screening outcome Among contacts of 984 successfully traced index patients Among contacts of 479 untraced index patients
Household contacts NCDRa Neighbor contacts NCDRa Household contacts NCDRa Neighbor contacts NCDRa
Positive 63 29 138 9 12 15 51 8
Negative 2,105 14,828 807 6,599
Total 2,168 14,966 819 6,650
a New case detection rate per 1000 screened individuals.
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comparison between the cumulative total number of new leprosy pa-
tients detected among contacts and the cumulative total number of
underlying index patients in relation to the number of years that have
passed since the diagnosis of the index patient shows an almost linear
increase between three and 12 years post-diagnosis of the index patient
(Fig. 2). Thus, new patients were found at similar rates among the
contacts of index patients diagnosed between 3 and 12 years prior to
the contact screening. The fraction of new leprosy patients among the
contacts was slightly lower two to three years after the diagnosis of the
index patient, as well as over 12 years after diagnosis.
3.3. Characteristics of leprosy patients diagnosed through routine services
and RACF
No systematic diﬀerence was observed between the traced and the
untraceable index patients in terms of their sex, age group, disability
grade and leprosy type (Table 2). However, relevant data were missing
for a large number of patients. The majority of the index patients that
were appropriately documented in the NLEP national database were
male, aged>15 years and had MB leprosy with DG0. The completeness
of the NLEP data was better for patients diagnosed in the years
2012–2015. If no systematic diﬀerence exists between the patients with
complete data and the other patients, the key demographic and leprosy
indicators of index patients diagnosed 2001–2010 and patients regis-
tered in the NLEP database between 2012 and 2015 appear to be
comparable.
The leprosy patients detected through RACF among the contacts of
index patients diagnosed between 2001 and 2010 were again pre-
dominantly male adults (Table 2). Of note, among household members
the same number of male and female patients was detected while
among neighbor contacts, male patients predominate. Very limited data
is available on disability among the new patients detected in the frame
of RACF. With regard to leprosy type, the fraction of patients with PB
leprosy is considerably higher among the new patients detected through
RACF, particularly among household members, when compared to the
national cohort of passively detected new patients between 2001 and
2010 and between 2012 and 2015.
3.4. Leprosy patients who had been diagnosed but not formally registered in
the national database
In the frame of the RACF activities, local Operational District re-
gistries were compared to the national leprosy database maintained by
NLEP. As a result, a total of 270 leprosy patients were identiﬁed which
had been diagnosed by local health services and received MDT but were
never registered in the NLEP national leprosy database. Among them,
71 (26.3%) had been diagnosed before 2001, 36 (13.3%) had been
diagnosed in 2001 or later, and for 163 (60.4%) no date of diagnosis is
available. Generally, information on these patients is very incomplete,
and no detailed analysis is possible to determine whether they are
systematically diﬀerent from the registered cohort. The drive teams
made an eﬀort to trace these patients and to screen their household
members and neighbors. This resulted in the detection of an additional
13 and 27 new leprosy patients among their household and neighbor
contacts, respectively. Both the 270 unlisted patients and the 40 new
patients among their contacts are not included in the presented data,
ﬁgures and tables due to the severe data incompleteness.
3.5. Eﬀectiveness of RACF as compared to routine activities
In 34 of the 54 visited ODs (63.0%), the number of newly diagnosed
leprosy patients was higher in the year of the drive compared to the
year before and after. The increase in the number of new leprosy pa-
tients detected in the ODs in the year of a drive was more pronounced
with regard to PB than MB patients, and was most clearly observed in
2012, 2013, and—to a somewhat lesser extent—2014 (Fig. 3). In 2015,
neither an impact of the drive on the total number of patients detected
nor on the proportion of patients with MB vs. PB leprosy can be ob-
served. The relatively high number of new leprosy patients diagnosed in
ODs visited in 2012 and 2013 compared to the later years can be ex-
plained by an initial focus of the drives on ODs with a high number of
index patients diagnosed in the baseline period 2001–2010. The high
baseline number would translate into a high number of contacts to be
screened and apparently also a high number of new leprosy patients in
the following period. No statement is possible at this point in time on
the longer-term impact of drives on the number of leprosy patients
detected in an OD since systematically collected follow-up data are not
yet available.
4. Discussion
The intention of this article is to widen the current discussions about
the most eﬀective combination of approaches to identify leprosy pa-
tients and thereby contribute to the interruption of transmission
(Bratschi et al., 2015). Cambodia is in a similar situation as many other
leprosy-endemic countries that have reached a relatively low NCDR of
Fig. 2. Cumulative total numbers of new leprosy patients and un-
derlying index patients in relation to the number of years since the
diagnosis of the index patients. The data are from the National
Leprosy Elimination Programme (NLEP) and the retrospective active
case ﬁnding (RACF) project in Cambodia. As the year of diagnosis was
not identiﬁable for 329 of the index patients, the ﬁgure is based on
data from 1,134 out of 1,463 index patients, which resulted in the
inclusion of 58 new leprosy patients in household members and 139
new leprosy patients in neighbors. The cumulative total number of
new leprosy patients detected in household members and neighbors is
indicated on the primary vertical scale on the left and—due to dif-
ferent magnitudes—the cumulative total number of underlying index
patients is indicated on the secondary vertical scale on the right.
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0.10 in 2016 (Anonymous, 2017) and now seek eﬀective ways to ensure
early diagnosis of new leprosy patients (Anonymous, 2016). A mobile
team of experienced staﬀ implementing RACF with the support from
local healthcare workers oﬀers a potential solution to multiple chal-
lenges common across low-endemic developing countries, including the
diminishing expertise among peripheral health staﬀ to recognize le-
prosy patients, the concentration of new leprosy patients among con-
tacts of index patients, and the need to raise awareness for the disease
(Smith et al., 2014). In response to these challenges, the highly struc-
tured RACF approach has been developed and applied in Cambodia.
The here presented ﬁrst evaluation of this approach indicates that it
could be more eﬀective than a decentralized system of contact tracing
and screening and it certainly facilitates the monitoring and quality
control of routine activities. Another strategy for active case ﬁnding,
namely population screening campaigns, are only recommended in
areas with a relatively high prevalence of leprosy (WHO, 2016). The
experience with RACF in Cambodia over the last years clearly demon-
strates that a RACF approach is feasible and contributes to early case
detection as indicated by the higher proportion of patients with PB
leprosy diagnosed during the drives compared to the respective pro-
portion in the routine data. However, it is equally clear that leprosy
control cannot be based on RACF with mobile teams alone since the
tracing of index patients and screening of their contacts critically de-
pends on a functioning passive case detection system, i.e. a basic ca-
pacity to diagnose leprosy must be maintained in the health system.
Last but not least, proper documentation including a national leprosy
database is essential. This is especially apparent in the relatively high
number of diagnosed leprosy patients that were not listed in the na-
tional leprosy database, and the high proportion of missing data even
for basic indicators such as sex of index patients. The drives oﬀered an
opportunity to update that database.
The following points are oﬀered for consideration when interpreting
the results of the RACF project in Cambodia. First, the project had a
rolling start with procedures and documentation being developed and
reﬁned over time. Hence, no detailed information about the ﬁrst three
drives is available and the present analysis focuses on data from drives
4–11. Of note, these ﬁrst three drives targeted ODs with a relatively
high number of leprosy patients, and resulted in the diagnosis of 277
leprosy patients among their contacts while drives 4–11 resulted in the
diagnosis of 264 new leprosy patients.
Second, an analysis of temporal trends within the RACF data must
take into consideration that districts with relatively higher NCDRs and
good accessibility were visited ﬁrst. This non-random selection might
be a main reason for the absence of any perceptible impact of RACF
activities on the total number of newly detected leprosy patients in
2015 (Fig. 3) when the districts with lowest priority—i.e. those with
lowest number of index patients and worst accessibility—were visited.
In order to provide further insights into the eﬀects of RACF on the le-
prosy epidemiology over time, the need for systematically collected
follow-up data cannot be overemphasized.
Third, no precise information is available on the fraction of eligible
contacts that have actually been traced and screened. The 1,463 index
patients belonged to 1,287 diﬀerent households in which an additional
2,987 household members were screened. Hence, on average, 3.5 in-
dividuals per household were documented. According to the 2013 Inter-
censal Population Survey of the Kingdom of Cambodia, the average
Cambodian household size was 4.6 individuals in 2013 (National
Institute of Statistics, 2013). According to these numbers, the RACF
drives 4–11 may have covered 70–80% of all household contacts, but
missed 1–2 individuals in each index patient household. While not
properly documented, the available evidence indicates that a lower
fraction of the neighbor contacts have been successfully traced and
screened. Thus, the coverage of the contacts with the highest risk of
disease, namely household contacts, was better than that of contacts
with a lower but in comparison to the general population still elevated
risk (Table 1 and (Moet et al., 2006)). In order to properly estimate
contact tracing rates among those most at risk and to better tailor RACF
eﬀorts (e.g. most eﬃcient deﬁnition of “contacts”), it seems advisable
to fully document activities also for neighbor contacts and to conduct
contact network analyses. Reportedly, the acceptance of leprosy
screening among contacts is high. While no detailed data have been
published with regard to leprosy, stigma was not perceived to be an
Table 2
Demographic and leprosy-speciﬁc characteristics of new leprosy patients detected through passive case detection and retrospective active case ﬁnding (RACF) in Cambodia, 2001–2015.
Data of patients detected through passive case detection were extracted from the National Leprosy Elimination Programme (NLEP) national leprosy database. Leprosy patients registered
in the NLEP national database between 2001 and 2010 were traced as index patients in the frame of the RACF project. In the table, the index patients are further stratiﬁed by tracing
status. Details on all leprosy patients registered in the NLEP national database between 2012 and 2015 are provided for comparison. RACF data pertain to drives 4–11 of the project,
conducted between 2012 and 2015.
Individual
characteristics
Numbers and percentages of new leprosy patients
New patients detected through passive case detection by NLEP New patients detected through RACF
2001–2010, index
patients traced in RACF
(%) 2001–2010, index









Male 481 (48.9) 271 (56.6) 692 (63.1) 37 (49.3) 110 (58.2)
Female 310 (31.5) 139 (29.0) 405 (36.9) 37 (49.3) 60 (31.7)
NA 193 (19.6) 69 (14.4) 0 (0.0) 1 (1.4) 19 (10.1)
Age group
Child (≤15 years) 32 (3.2) 18 (3.8) 103 (9.4) 5 (6.7) 10 (5.3)
Adult (> 15 years) 664 (67.5) 188 (39.2) 994 (90.6) 33 (44.0) 78 (41.3)
NA 288 (29.3) 273 (57.0) 0 (0.0) 37 (49.3) 101 (53.4)
Disability grade
No disability 395 (40.1) 231 (48.2) 1006 (91.7) 0 – 0 –
Disability grade I 93 (9.5) 39 (8.1) 32 (2.9) 1 (1.4) 0 (0.0)
Disability grade II 116 (11.8) 55 (11.5) 59 (5.4) 4 (5.3) 11 (5.8)
NA 380 (38.6) 154 (32.2) 0 (0.0) 70 (93.3) 178 (94.2)
Leprosy type
Paucibacillary 235 (23.9) 120 (25.1) 533 (48.6) 52 (69.3) 85 (45.0)
Multibacillary 555 (56.4) 288 (60.1) 564 (51.4) 23 (30.7) 83 (43.9)
NA 194 (19.7) 71 (14.8) 0 (0.0) 0 (0.0) 21 (11.1)
NA: not available.
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issue in a home TB screening project in Cambodia (Lorent et al., 2015).
Fourth, the achievements of the passive case detection system and
the RACF should not be compared competitively, but rather interpreted
as mutually enhancing. Due to its dependence on index patient in-
formation, RACF should be most eﬃcient in areas where a high pro-
portion of local leprosy patients have been diagnosed and properly
documented. However, in such areas the number of undiagnosed new
leprosy patients still to be detected through RACF would be lower than
in an area with weak capacity at the level of the local health system. On
the other hand, a certain proportion of new patients diagnosed in the
frame of RACF would most likely have been picked up by the passive
case detection system later in the same year. Moreover, RACF also aims
to inﬂuence the behavior of the local population. For instance, sensi-
tization and encouragement to self-refer to a health center in case of a
symptom suggestive of leprosy is an integral aspect of the drives.
However, likewise, it is conceivable that a negative screening outcome
provides a false sense of safety and distracts individuals from seeking
care in time.
In the light of the continuing absence of routine contact tracing and
screening of newly diagnosed leprosy patients in Cambodia, a second
phase of the RACF project in Cambodia has been designed and became
operational in late 2016. It focuses on 31 high-priority districts selected
based on a relatively high NCDR and a comparatively high proportion
of pediatric, MB and male leprosy patients. In the frame of the second
phase, post-exposure prophylaxis (PEP) with single dose rifampicin
(SDR) is oﬀered to eligible contacts in the household of the index pa-
tient and its ﬁve most immediate neighbor households, which is in line
with the general outline of the Leprosy Post-Exposure Prophylaxis
(LPEP) programme (Barth-Jaeggi et al., 2016). The documentation of
the second phase will also be aligned with the standards established for
the LPEP programme, part of which Cambodia will thus become. An-
other focus of the second phase will be the contact tracing rate, which
should be further increased to maximize the impact of the drives on the
NCDR and leprosy transmission. Last, a rigorous surveillance protocol is
being applied to further improve the quality of the ﬁeld procedures and
the completeness of the patient and project documentation.
5. Conclusion
The RACF approach with mobile teams was found to be feasible and
eﬀective in detecting new leprosy patients among the contacts of pre-
viously registered patients. The concentrated eﬀort of a small team of
trained leprosy specialists supported by local staﬀ allowed the eﬃcient
tracing and screening of contacts without the need to establish a na-
tional system for contact tracing. However, basic capacity to diagnose
leprosy must still be maintained in the health system to ensure the
correct diagnosis of self-referred patients. Furthermore, a well-main-
tained national leprosy database is essential. The addition of SDR PEP
could considerably increase the impact of RACF on transmission, and
together the two approaches might oﬀer an interesting option for
countries with a relatively low number of new leprosy patients but
evidence of ongoing transmission.
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